Understanding Clinical Research for Mild Cognitive Impairment
This study is looking at how people with Mild Cognitive Impairment (MCI) experience clinical research. It aims to understand what helps or hinders someone from joining and completing a study. Researchers will collect a lot of information about participants' experiences to see if certain factors or demographic groups (like age or background) affect participation. The goal is to learn how to make future studies better for people with MCI. You can join if you are 18 or older with a confirmed MCI diagnosis and are willing to follow study requirements. The study is currently unclear on its recruitment status.
- Study design
- This is an observational study planning to enroll 500 participants. It will track how many patients decide to enroll in a study (measured at 3 months) and how many complete it (measured at 12 months).
- What's involved
- You must be willing and able to comply with scheduled visits, laboratory tests, and other requirements of the study.
- Compensation
- Not stated in the trial record.
- Follow-up
- Participants will be followed to see if they complete a clinical study, measured at 12 months.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Navigating the Clinical Research Process for Mild Cognitive Impairment
At a glance
Conditions
NCT06207903
Where you'd take part
This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.
Power Life Sciences
San Francisco, Californiastudy coordinator listed
Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.
Study leadership
- Michael B Gill · STUDY_DIRECTOR · Power Life Sciences Inc.
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Want this trial checked against your situation?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Rate of patients who decide to enroll in a mild cognitive impairment clinical research.3 months
- Number of mild cognitive impairment study participants who remain in clinical study until completion.12 months